scispace - formally typeset
Proceedings ArticleDOI

iQuant™ Analyser: A rapid quantitative immunoassay reader

TLDR
The iQuant Analyser is a portable, easy to use rapid quantitative immunoassay reader best suited for point of care applications and repeatability of the instrument was found to be excellent.
Abstract
Lateral flow immunoassays (LFIA) used in rapid quantitative point of care testing require an accurate, reliable and easy to operate instrument to read the LFIA kit and calculate the quantitative result value. We present iQuant® Analyser, an immunoassay reader designed for reading the Quanti® range of LFIA test kits for key markers such as HbA1C, Vitamin D, TSH etc. The instrument utilizes a laser based confocal optics system to capture the test and control lines from the LFIA kit, digitizes the fluorescent signal with high spatiotemporal resolution, computes necessary peak area ratios, applies calibration curves and declares the final result in an automated manner with minimal operator input. The instrument uses kit specific calibration information embedded on each LFIA test kit, to compute the final clinical parameter without using any external calibration chip. An intuitive icon based interface enables easy operation with minimal key presses, suited for point of care applications. The technology is designed in a modular manner to enable the instrument to perform tests on various parameters such as HbA1C, TSH, and Vitamin D etc without any hardware changes, using test-specific LFIA kits. The functional performance of the iQuant Analyser was verified over the range of expected area ratio values with standard reference cartridges that provided stable fluorescent lines. Repeatability of the instrument was found to be excellent with coefficient of variation (CoV) of area ratios found to be less than 1%. The inter-instrument reproducibility was also found to be good with CoV less than 4 %. Tests using blood samples with Quanti LFIA kits verified the accuracy of HbA1C results to be acceptable as per international standards with errors < 4 %. The iQuant Analyser is a portable, easy to use rapid quantitative immunoassay reader best suited for point of care applications.

read more

Citations
More filters
Journal ArticleDOI

A Cellulose Paper-Based Fluorescent Lateral Flow Immunoassay for the Quantitative Detection of Cardiac Troponin I.

TL;DR: In this article, a lateral flow assay (LFA) was used for the quantitative, fluorescence-based detection of the cardiac biomarker troponin I (cTnI) that features an analytical strip made of cellulose filter paper.
Journal ArticleDOI

Development and Evaluation of a Quantitative Fluorescent Lateral Flow Immunoassay for Cystatin-C, a Renal Dysfunction Biomarker.

TL;DR: In this article, a rapid, quantitative immunoassay for the detection of cystatin-C was proposed, where a fluorescence-based lateral flow kit was developed in a sandwich format by using a monoclonal antibody.
Proceedings ArticleDOI

An Improved System for Quantitative Immunoassay Measurement in ImageQuant

TL;DR: ImageQuant Analyzer's evolved hardware and software algorithm is described and improvements in TSH analyte from human sera samples were analyzed to validate improvements.
Journal ArticleDOI

A novel point-of-care device accurately measures thyrotropin in whole blood, capillary blood and serum

TL;DR: The Wondfo system was straightforward to use without need for specialist technicians and demonstrated analytic performance suitable for clinical use for the diagnosis of thyroid dysfunction.
Journal ArticleDOI

Exploring carbohydrate binding module fusions and Fab fragments in a cellulose-based lateral flow immunoassay for detection of cystatin C

TL;DR: In this paper , a lateral flow assay (LFA) was proposed for the quantitative, fluorescence-based detection of the kidney biomarker cystatin C that features conjugates of capture antibodies and fusions of carbohydrate binding modules (CBM) with ZZ domains anchored on cellulose deposited over nitrocellulose.
References
More filters
BookDOI

Lateral flow immunoassay

TL;DR: Manufacturing the Next Generation of Highly Sensitive and Reproducible Lateral Flow Immunoassay Tests and Quantitative, False Positive, and False Negative Issues for Lateral flow immunoassays as Exemplified by Onsite Drug Screens are studied.

Point-of-care diagnostics, a major opportunity for change in traditional diagnostic approaches: potential and

TL;DR: This review focuses on antibody-based POC devices that target four major global diseases: cardiovascular diseases, prostate cancer, HIV infection and tuberculosis.
Journal ArticleDOI

Point-of-care diagnostics, a major opportunity for change in traditional diagnostic approaches: potential and limitations

TL;DR: In this article, the authors focus on antibody-based point-of-care (POC) devices that target four major global diseases: cardiovascular diseases, prostate cancer, HIV infection and tuberculosis.
Related Papers (5)